Ares Trading S.A. - May 12, 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: 10%+ Owner
Signature: /s/ Cedric Hyde, Authorized Signatory of Merck Serono SA
Stock symbol: PGEN
Transactions as of: May 12, 2021
Transactions value $: -$1,848,694
Form type: 4
Date filed: 5/14/2021, 06:02 PM
Previous filing: May 12, 2021
Next filing: May 14, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Sale	-$1.05M	-150K	-0.57%	$7.00^*	26.4M	May 12, 2021	Direct	F1
transaction	PGEN	Common Stock	Sale	-$798K	-122K	-0.46%	$6.52	26.3M	May 13, 2021	Direct	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ares Trading, S.A. on April 29, 2021.

Remarks:

This Form 4 is being filed by each of the following persons (together, the Reporting Persons): Ares Trading SA, the direct beneficial owner of the shares, Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany, an indirect beneficial owner of the shares, and Merck KGaA, Darmstadt, Germany, an indirect beneficial owner of the shares. Ares Trading SA is a dominantly controlled subsidiary of Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany. Merck Serono SA, Aubonne, Switzerland is a wholly owned I indirect subsidiary of Merck KGaA, Darmstadt, Germany. Merck KGaA, Darmstadt, Germany is a publicly traded company (Frankfurt Stock Exchange, DAX 30) and the beneficiary of the two companies.